[{"address1": "12278 Scripps Summit Drive", "city": "San Diego", "state": "CA", "zip": "92131", "country": "United States", "phone": "858 875 1800", "website": "https://www.fatetherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma; FT836 whiuch is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, and FT825 to treat solid tumors.It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.", "fullTimeEmployees": 181, "companyOfficers": [{"maxAge": 1, "name": "Dr. Bahram  Valamehr M.B.A., Ph.D.", "age": 47, "title": "President, CEO & Director", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 676600, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Cindy R. Tahl J.D.", "age": 51, "title": "Chief Legal & Compliance Officer and Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 644600, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Victor  Hong", "title": "Vice President of Corporate Development & Finance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jessica  Francis", "title": "Vice President Of Human Resources & Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Henry", "age": 60, "title": "Senior Vice President of Clinical Operations", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tunde  Babalola", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Yu  Cai", "title": "Head of Intellectual Property & Assistant General Counsel", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kate  Duvall", "title": "Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 3, "compensationRisk": 5, "shareHolderRightsRisk": 10, "overallRisk": 7, "governanceEpochDate": 1756684800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.9708, "open": 0.97, "dayLow": 0.9512, "dayHigh": 1.01, "regularMarketPreviousClose": 0.9708, "regularMarketOpen": 0.97, "regularMarketDayLow": 0.9512, "regularMarketDayHigh": 1.01, "payoutRatio": 0.0, "beta": 2.216, "forwardPE": -0.5952381, "volume": 1302890, "regularMarketVolume": 1302890, "averageVolume": 1444087, "averageVolume10days": 1350920, "averageDailyVolume10Day": 1350920, "bid": 0.6875, "ask": 1.24, "bidSize": 2, "askSize": 2, "marketCap": 115329696, "fiftyTwoWeekLow": 0.66, "fiftyTwoWeekHigh": 3.8, "allTimeHigh": 121.16, "allTimeLow": 0.66, "priceToSalesTrailing12Months": 13.616257, "fiftyDayAverage": 1.0642, "twoHundredDayAverage": 1.21005, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -26166304, "profitMargins": 0.0, "floatShares": 100797002, "sharesOutstanding": 115329697, "sharesShort": 9877527, "sharesShortPriorMonth": 9401919, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.0856, "heldPercentInsiders": 0.01706, "heldPercentInstitutions": 0.78689003, "shortRatio": 7.01, "shortPercentOfFloat": 0.09770001, "impliedSharesOutstanding": 115329697, "bookValue": 2.28, "priceToBook": 0.4385965, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -171522000, "trailingEps": -1.46, "forwardEps": -1.68, "enterpriseToRevenue": -3.089, "enterpriseToEbitda": 0.162, "52WeekChange": -0.71428573, "SandP52WeekChange": 0.1529237, "quoteType": "EQUITY", "currentPrice": 1.0, "targetHighPrice": 8.0, "targetLowPrice": 2.0, "targetMeanPrice": 4.45, "targetMedianPrice": 4.5, "recommendationKey": "none", "numberOfAnalystOpinions": 10, "totalCash": 222830000, "totalCashPerShare": 1.932, "ebitda": -161604992, "totalDebt": 81331000, "quickRatio": 7.89, "currentRatio": 8.035, "totalRevenue": 8470000, "debtToEquity": 31.118, "revenuePerShare": 0.072, "returnOnAssets": -0.24659, "returnOnEquity": -0.52107, "grossProfits": -106806000, "freeCashflow": -60912500, "operatingCashflow": -115614000, "revenueGrowth": -0.718, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -19.38542, "financialCurrency": "USD", "symbol": "FATE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Fate Therapeutics, Inc.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1758928668, "regularMarketTime": 1758916801, "exchange": "NGM", "messageBoardId": "finmb_39268712", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Fate Therapeutics, Inc.", "regularMarketChangePercent": 3.00783, "regularMarketPrice": 1.0, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1380634200000, "postMarketChangePercent": 0.96999407, "postMarketPrice": 1.0097, "postMarketChange": 0.009699941, "regularMarketChange": 0.0292, "regularMarketDayRange": "0.9512 - 1.01", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1444087, "fiftyTwoWeekLowChange": 0.33999997, "fiftyTwoWeekLowChangePercent": 0.51515144, "fiftyTwoWeekRange": "0.66 - 3.8", "fiftyTwoWeekHighChange": -2.8, "fiftyTwoWeekHighChangePercent": -0.7368421, "fiftyTwoWeekChangePercent": -71.42857, "earningsTimestampStart": 1762891200, "earningsTimestampEnd": 1762891200, "earningsCallTimestampStart": 1715288400, "earningsCallTimestampEnd": 1715288400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.46, "epsForward": -1.68, "epsCurrentYear": -1.10211, "priceEpsCurrentYear": -0.9073504, "fiftyDayAverageChange": -0.06420004, "fiftyDayAverageChangePercent": -0.060327046, "twoHundredDayAverageChange": -0.21004999, "twoHundredDayAverageChangePercent": -0.17358786, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Fate Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-09-27"}]